(Q33374197)

26 July 2017

title

Eflornithine treatment of refractory Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome (English)

1 reference

26 July 2017

Eflornithine Treatment of Refractory Pneumocystis carinii Pneumonia in Patients with Acquired Immunodeficiency Syndrome (English)

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

10 November 2022

0 references

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

10 November 2022

Pneumocystis carinii

object named as

Pneumocystis carinii

1 reference

Y. J. Paulson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729113

10 November 2022

T. M. Gilman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729113

10 November 2022

P. N. Heseltine

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729113

10 November 2022

O. P. Sharma

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729113

10 November 2022

C. T. Boylen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729113

10 November 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

full work available at URL

26 July 2017

https://api.elsevier.com/content/article/PII:S0012369216331233?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

https://api.elsevier.com/content/article/PII:S0012369216331233?httpAccept=text/plain

10 November 2022

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

10 November 2022

1 reference

26 July 2017

volume

101

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

67-74

1 reference

Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia

26 July 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Pneumocystis carinii pneumonia: diagnosis

10 November 2022

3

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial

10 November 2022

4

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other Immunodeficiencies

10 November 2022

5

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Adverse Reactions to Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency Syndrome

10 November 2022

6

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Polyamine metabolism and function

10 November 2022

10

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Chemotherapeutic implications of polyamine biosynthesis inhibition

10 November 2022

11

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Prediction of creatinine clearance from serum creatinine

10 November 2022

15

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS)

10 November 2022

16

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Are corticosteroids beneficial as adjunctive therapy for Pneumocystis pneumonia in AIDS?

10 November 2022

17

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Kinetics of alpha-difluoromethylornithine: an irreversible inhibitor of ornithine decarboxylase

10 November 2022

18

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study

10 November 2022

19

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Inhaled or reduced-dose intravenous pentamidine for Pneumocystis carinii pneumonia. A pilot study.

10 November 2022

20

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Pneumocystis carinii pneumonia treated with pyrimethamine and sulfadiazine

10 November 2022

22

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Fatal Toxic Epidermal Necrolysis During Prophylaxis With Pyrimethamine and Sulfadoxine in a Human Immunodeficiency Virus—Infected Person

10 November 2022

23

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Adverse reactions associated with pyrimethamine-sulfadoxine prophylaxis for Pneumocystis carinii infections in AIDS

10 November 2022

24

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone

10 November 2022

25

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome

10 November 2022

26

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Trimetrexate-leucovorin dosage evaluation study for treatment of Pneumocystis carinii pneumonia

10 November 2022

27

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome

10 November 2022

28

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome

10 November 2022

29

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Inhaled or intravenous pentamidine therapy for Pneumocystis carinii pneumonia in AIDS. A randomized trial.

10 November 2022

30

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial

10 November 2022

31

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.67

10 November 2022

Identifiers

1 reference

26 July 2017

1 reference